Naya Capital Adds Masimo Shares

Company Overview - Masimo is a leading provider of advanced noninvasive monitoring solutions, focusing on technologies that improve patient care and operational efficiency in healthcare settings [4] - The company develops and markets noninvasive patient monitoring technologies, including pulse oximetry, brain function monitoring, capnography, regional oximetry, hemodynamic monitoring, and hospital automation platforms [8] Financial Metrics - As of market close on February 18, Masimo's stock price was $175.61, with a market capitalization of $9.4 billion [3] - The company's revenue for the trailing twelve months (TTM) was $1.7 billion, while the net income for the same period was a loss of $203.8 million [3] Recent Developments - Naya Capital Management UK Ltd disclosed a new position in Masimo, acquiring nearly 1.6 million shares valued at approximately $203 million, which represents 15.3% of the fund's disclosed assets [5][7] - This acquisition marks Naya Capital's fifth-largest position among its five disclosed holdings, which total over $1.3 billion [5][7] Market Performance - Masimo's shares experienced a significant increase of over 34%, rising from $130.15 to $174.69 on February 17, following the announcement that Danaher would acquire the company for $9.9 billion, or $180 a share, in cash [9] - Despite the recent share price increase, Masimo's shares lost 2.6% over the year leading up to February 17, while the S&P 500 and NASDAQ Composite returned 13.7% and 14.3%, respectively [6]